ArticleOpen forum infectious diseases2025

Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort.

Emma Davies Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.